Compare Ford Motor Company (F) vs Twist Bioscience Corp (TWST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ford Motor Company vs Twist Bioscience Corp — how do they compare? Ford Motor Company trades at $12.17 (market cap $48.85B), while Twist Bioscience Corp trades at $159.78 (market cap $10.08B). The key difference: Ford Motor Company is far larger — about 4.8× Twist Bioscience Corp's market cap, and Ford Motor Company pays a 4.9% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals — on Pluang, investors hold Ford Motor Company for 105 Days and Twist Bioscience Corp for 27 Days on average.
| F | TWST | |
|---|---|---|
Market Cap | $48.85B | $10.08B |
Volume | 57,748,965 | 4,229,037 |
Sector | Consumer Cyclical | Health |
52-Week High | $17.44 | $205.00 |
52-Week Low | $11.21 | $25.45 |
Typical Hold Time | 105 Days | 27 Days |
Enterprise Value | $180.81B | $10.01B |
Dividend Yield | 4.9% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Ford Motor Company (F) trades at $12.17, up 0.37% with a bearish technical outlook despite recent earnings beats. The company shows mixed fundamentals with $187.27B revenue but negative net income margin of -3.93% and concerning debt-to-asset ratio of 56.49%. Recent news highlights sales declines and production challenges, though the company maintains strong cash flow from operations of $21.28B. Analyst consensus remains cautiously optimistic with a $15.90 price target despite near-term headwinds.
Ford faces significant execution risks amid declining sales and competitive pressures, but valuation metrics appear attractive with P/E of 11.21 and P/S of 0.26. The hybrid vehicle transition and strong commercial division provide potential upside, though investors must weigh debt levels and margin pressures against the discounted valuation and analyst price target suggesting 30% upside potential.
Twist Bioscience (TWST) trades at $159.78, up 2.65% today, showing strong momentum despite mixed technical signals. The company continues to demonstrate robust revenue growth, with 2025 revenue reaching $377 million, though profitability remains elusive with a -31.66% net income margin. Recent positive developments include a strategic partnership with Eli Lilly's TuneLab AI platform announced September 16, 2026, driving investor optimism about the company's AI-driven drug discovery capabilities.
While analyst consensus remains bullish with 73% buy ratings, the stock faces significant fundamental challenges including persistent cash burn and negative earnings. The current price exceeds the $145.20 consensus target, suggesting limited near-term upside. Key risks include execution challenges in achieving profitability and dependence on AI partnerships for growth catalysts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ford Motor Company
Ford Motor Company designs, manufactures, and services cars and trucks. The Company also provides vehicle-related financing, leasing, and insurance through its subsidiary.
Read more on F →About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →
